Related Experiment Video
Updated: Jan 7, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Bioengineered Microrobot for Targeted and Autonomous Eradication of Helicobacter pylori
Shali Tan1, Ruijue Dan1, Junfeng Guo1
1Department of Gastroenterology, Xinqiao Hospital, NO.183, Chongqing, China.
A novel bioengineered robotic system offers targeted eradication of Helicobacter pylori (H. pylori) infection. This icebreaker-inspired micro-robot system demonstrates superior efficacy and biocompatibility, addressing antibiotic resistance challenges.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Microbiology
Background:
- Helicobacter pylori (H. pylori) infection is a significant challenge in gastric disease treatment.
- Conventional antibiotic therapies face limitations including poor gastric retention, lack of specificity, and increasing bacterial resistance.
- There is a critical need for innovative therapeutic strategies to overcome these challenges.
Purpose of the Study:
- To develop and evaluate a novel bioengineered robotic system for targeted and efficient H. pylori eradication.
- To address the limitations of conventional H. pylori therapies through advanced nanotechnology and bioengineering.
- To investigate the system's efficacy in vitro and in vivo for H. pylori clearance and mitigation of associated inflammation.
Main Methods:
- A multi-functional micro-robot system was engineered, combining platinum nanozymes, calcium carbonate, chitosan, gastric cell membranes, and pronase.
- The system utilizes autonomous motility propelled by carbon dioxide generation upon exposure to gastric acid.
- In vitro and in vivo studies were conducted to assess antibacterial activity, biocompatibility, and therapeutic effects on H. pylori infection.
Main Results:
- The bioengineered micro-robots demonstrated enhanced gastric retention, precision targeting, and efficient H. pylori eradication.
- Pronase facilitated mucus barrier penetration, while platinum nanozymes ensured deep bacterial clearance.
- The system showed superior antibacterial activity, excellent biocompatibility, and effectively mitigated H. pylori-induced inflammation.
- Intestinal microbiota balance was preserved during treatment.
Conclusions:
- The novel bioengineered robotic system represents a paradigm shift in H. pylori therapy.
- This technology offers a precise, efficient, and resistance-mitigating alternative to conventional treatments.
- The system's multi-modal mechanism and autonomous propulsion overcome key limitations of current H. pylori eradication strategies.
More Related Videos
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Biological Methods for Microbial Control

